Dr Reddy's Labortaries becomes one among the first to introduce Semaglutide injection used in type-2 diabetes treatment in the Canadian market. The launch follows their successful launch in India under the brand name Obeda, CEO Erez Israeli said
A research team led by Dr. Manjula Reddy at Hyderabad’s Centre for Cellular and Molecular Biology (CCMB) has discovered a crucial proofreading mechanism in bacteria that helps maintain the strength of their cell walls.
The undertaking to Delhi HC follows a patent infringement plea filed by the Danish drugmaker against Dr Reddy’s Laboratories and OneSource Speciality Pharma. Novo Nordisk’s blockbuster weight-loss drug Ozempic Wegovy is expected to be launched soon in India
The US Food & Drug Administration (USFDA) completed a GMP inspection at the company's API (active pharmaceutical ingredients) manufacturing facility (CTO-5) in Miryalaguda, Telangana, the Hyderabad-based drug maker said
The US Food and Drug Administration completed a Good Manufacturing Practice (GMP) inspection at the company's API (active pharmaceutical ingredients) Middleburgh facility in New York, Dr Reddy's said in a regulatory filing
Hyderabad: Hyderabad-headquartered Dr Reddy’s Laboratories (DRL) said its consolidated profit after tax (PAT) for the July-September quarter was up 12 per cent at Rs 1,112.8 crore as against Rs 992 crore in the same quarter a year ago. Its revenues during the quarter were up nine per cent to Rs 6,305.7 crore compared to Rs […]
New Delhi: Covid antiviral drug Molnupiravir was on Monday launched in India at Rs 1,399 for a five-day course for mild to moderate infection. Amid rising cases of new Covid variant Omicron in the country, an expert panel of the Central Drugs Standard Control Organisation had recently approved antiviral drug Molnupiravir for restricted use in […]
While vaccinations and several treatment options are now available, rapid spread of the infection has led to further uncertainties in terms of business outlook, the drug major said in its Annual Report for 2020-21.
Dr Reddy's which had received over two lakh vaccines from RDIF, recently soft-launched Sputnik V and tied up with Apollo Hospitals for piloting the vaccine.
Dr Reddy's Laboratories, the marketing partner for the Russian vaccine, announced that it commenced the soft launch on Friday as part of a limited pilot.
The imported doses of the vaccine are presently priced at Rs 995 (Rs 948 plus 5 per cent GST per dose), with the possibility of a lower price point when local supply begins.
